Funded Tech Companies
VectorY
Looking for the VC firms that provided funding to VectorY? Insight Venture Partners, BioGeneration Ventures and Forbion Growth Opportunities Fund II joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
VectorY
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Science Park Matrix Innovation Center 408
Amsterdam, 1098 XH
NL
Amsterdam, 1098 XH
NL
Phone
Website
Email Address
Company Background Information
Overview
We are an Amsterdam-based biotech company founded in 2020 with a mission to develop vectorized antibody treatments for people with neurodegenerative diseases, enabling longer, better lives. Antibody treatments have wide applicability in neurodegenerative diseases that are known to be complex and difficult to treat. Our cutting-edge vectorized antibody technology combines highly selective therapeutic antibodies with one-time AAV-based delivery to the CNS. We are advancing a development pipeline of potentially disease-modifying treatments for ALS, Huntington's, and Parkinson's disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/14/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sander Deventer
Chief Financial Officer
Michael Wyzga
Chief Scientific Officer
Pavlina Konstantinova
Chief Technical Officer
Barbara Sanders
Company Investors
- Insight Venture Partners
- BioGeneration Ventures
- Forbion Growth Opportunities Fund II
- MRL Ventures (Karin Kleinhans)
- EQT Life Sciences
- Forbion Ventures Fund VI (Wouter Joustra)
- ALS Investment Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs